Study on the stability of PT, aPTT, and fibrinogen in lyophilized plasma for external quality control

Study on the stability of PT, aPTT, and fibrinogen in lyophilized plasma for external quality control

Authors

Keywords:

aPTT test, coagulation, external quality assessment, fibrinogen test, lyophilized plasma, PT test.

Abstract

Background and aim: The stability of PT, aPTT, and fibrinogen in lyophilized fresh plasma is an important topic in medical research and applications, especially in quality control programs and coagulation testing. To study the stability of PT, aPTT, and fibrinogen indices in lyophilized plasma according to the ISO 13528 and ISO 33405 standards, applied to the external quality assessment program for coagulation.

Methods: An experimental study on external quality control samples of lyophilized plasma with PT, aPTT, and fibrinogen indices. Fresh frozen plasma from the Blood Hospital was negative for HBV, HCV, HIV, malaria, and syphilis. The t-test assessed sample stability at different time points and temperatures. 200 samples were produce for each lot. Picking randomly total 35 samples for checking stability. The automatic coagulation analyzer CS-2000i from Sysmex was used. Using One-way ANOVA and t-test.

Results: Lyophilized plasma containing PT, aPTT, and fibrinogen indices maintained stability when stored at temperatures of 2-8°C and -20°C for up to 3 months, with stability during transport for up to 7 days.

Conclusions: Lyophilized plasma containing PT, aPTT, and fibrinogen indices maintained stability when stored at two temperatures, 2-8°C and -20°C, and remained stable during transportation throughout the study period.

References

1. Vilar R, Fish RJ, Casini A, Neerman-Arbez M. Fibrin(ogen) in human disease: both friend and foe. Haematologica. 2020;105(2):284-296. doi:10.3324/haematol.2019.236901

2. Vo TT, Le THM, Trinh THC, et al. Common alpha globin deletion mutation spectrum in hemoglobin H disease patients in the Mekong Delta, Vietnam. Asian Medical Journal and Alternative Medicine. 04/27 2023;23(1):9-16.

3. Mthabisi Talent George Moyo TAaHE. ISO 10993-4 Compliant Hemocompatibility Evaluation of Gellan Gum Hybrid Hydrogels for Biomedical Applications. Gel. 2024;doi:10.3390/gels10120824

4. Peng HT, Singh K, Rhind SG, da Luz L, Beckett A. Dried Plasma for Major Trauma: Past, Present, and Future. Life. 2024;14(5):619. DOI: 10.3390/life14050619

5. Bux J, Dickhörner D, Scheel E. Quality of freeze-dried (lyophilized) quarantined single-donor plasma. Transfusion. Dec 2013;53(12):3203-9. doi:10.1111/trf.12191

6. Marlar RA, Clement B, Gausman J. Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations. Semin Thromb Hemost. 2017;43(3):253-260. doi:10.1055/s-0036-1581128

7. Woodhams B, Girardot O, Blanco MJ, Colesse G, Gourmelin Y. Stability of coagulation proteins in frozen plasma. Blood Coagul Fibrinolysis. 2001;12(4):229-36. doi:10.1097/00001721-200106000-00002

8. Jennings I, Kitchen DP, Woods TA, Kitchen S, Preston FE, Walker ID. Stability of coagulation proteins in lyophilized plasma. Int J Lab Hematol. 2015;37(4):495-502. doi:10.1111/ijlh.12318

9. Zur M, Glassberg E, Gorenbein P, et al. Freeze-dried plasma stability under prehospital field conditions. Transfusion. 2019;59(11):3485-3490. doi:10.1111/trf.15533

Downloads

Published

24-04-2025

How to Cite

1.
Nguyen TH, Tran TT, Huynh TDP, Vu H. Study on the stability of PT, aPTT, and fibrinogen in lyophilized plasma for external quality control. Acta Biomed. 2025;96(2):16974. doi:10.23750/abm.v96i2.16974

Issue

Section

ORIGINAL CLINICAL RESEARCH

How to Cite

1.
Nguyen TH, Tran TT, Huynh TDP, Vu H. Study on the stability of PT, aPTT, and fibrinogen in lyophilized plasma for external quality control. Acta Biomed. 2025;96(2):16974. doi:10.23750/abm.v96i2.16974